Philippe Vennin

1.8k total citations
56 papers, 1.1k citations indexed

About

Philippe Vennin is a scholar working on Genetics, Oncology and General Health Professions. According to data from OpenAlex, Philippe Vennin has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 19 papers in Oncology and 12 papers in General Health Professions. Recurrent topics in Philippe Vennin's work include BRCA gene mutations in cancer (23 papers), Global Cancer Incidence and Screening (10 papers) and Breast Cancer Treatment Studies (7 papers). Philippe Vennin is often cited by papers focused on BRCA gene mutations in cancer (23 papers), Global Cancer Incidence and Screening (10 papers) and Breast Cancer Treatment Studies (7 papers). Philippe Vennin collaborates with scholars based in France, United States and Belgium. Philippe Vennin's co-authors include Jean‐Philippe Peyrat, François Eisinger, Hagay Sobol, Jacques Bonneterre, Claire Julian‐Reynier, J Lefèbvre, M M Louchez, Claude Fournier, Catherine Noguès and F Chabal and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Philippe Vennin

52 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Vennin France 17 495 310 231 182 181 56 1.1k
Kristen M. Shannon United States 19 771 1.6× 419 1.4× 342 1.5× 312 1.7× 82 0.5× 43 1.5k
Anne Dørum Norway 24 865 1.7× 553 1.8× 332 1.4× 265 1.5× 92 0.5× 71 1.8k
Richard M. Brohet Netherlands 12 710 1.4× 369 1.2× 204 0.9× 337 1.9× 57 0.3× 16 1.1k
Amy Finch Canada 18 1.1k 2.2× 333 1.1× 198 0.9× 205 1.1× 71 0.4× 29 1.6k
Rochelle Demsky Canada 13 458 0.9× 231 0.7× 103 0.4× 101 0.6× 49 0.3× 25 686
Julie Dutil Puerto Rico 20 546 1.1× 157 0.5× 393 1.7× 150 0.8× 119 0.7× 64 1.1k
Dana Zakalik United States 14 286 0.6× 313 1.0× 143 0.6× 180 1.0× 58 0.3× 35 792
Susan Randall Armel Canada 21 963 1.9× 536 1.7× 331 1.4× 352 1.9× 35 0.2× 51 1.5k
Shu Yuasa Japan 11 482 1.0× 1.1k 3.6× 182 0.8× 295 1.6× 103 0.6× 29 1.7k
Mary‐Anne Young Australia 23 1.0k 2.1× 545 1.8× 242 1.0× 268 1.5× 26 0.1× 78 1.7k

Countries citing papers authored by Philippe Vennin

Since Specialization
Citations

This map shows the geographic impact of Philippe Vennin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Vennin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Vennin more than expected).

Fields of papers citing papers by Philippe Vennin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Vennin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Vennin. The network helps show where Philippe Vennin may publish in the future.

Co-authorship network of co-authors of Philippe Vennin

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Vennin. A scholar is included among the top collaborators of Philippe Vennin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Vennin. Philippe Vennin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blein, Sophie, Laure Barjhoux, Francesca Damiola, et al.. (2015). Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2. PLoS ONE. 10(9). e0136192–e0136192. 9 indexed citations
2.
Ceugnart, L., et al.. (2014). Organized breast screening: Answers to recurring controversies. Diagnostic and Interventional Imaging. 95(4). 355–359. 6 indexed citations
3.
Kolesnikov-Gauthier, H., Laurence Vanlemmens, Marie‐Christine Baranzelli, et al.. (2011). Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG–PET after the first course. Breast Cancer Research and Treatment. 131(2). 517–525. 38 indexed citations
4.
Taïeb, S., N. Rocourt, Fabrice Narducci, et al.. (2011). Inefficacité du dépistage des cancers tubo-ovariens dans les situations de risque héréditaire de cancer de l’ovaire ; l’expérience du Centre Oscar-Lambret. Bulletin du Cancer. 98(2). 113–119. 3 indexed citations
5.
Julian‐Reynier, Claire, Anne‐Déborah Bouhnik, Christine Lasset, et al.. (2010). Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics. Genetics in Medicine. 12(12). 801–807. 30 indexed citations
6.
Ceugnart, L., S. Taïeb, Philippe Vennin, et al.. (2008). Place de l’IRM dans le bilan préchirurgical du cancer du sein : pour une utilisation raisonnée de cet examen complémentaire du bilan mammo-échographique. Journal de Radiologie. 89(11). 1774–1778. 1 indexed citations
7.
Mancini, Julien, Catherine Noguès, Claude Adenis, et al.. (2006). Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing. European Journal of Cancer. 42(7). 871–881. 39 indexed citations
8.
Mancini, Julien, Catherine Noguès, Claude Adenis, et al.. (2006). Patients’ characteristics and rate of Internet use to obtain cancer information. Journal of Public Health. 28(3). 235–237. 32 indexed citations
9.
Vennin, Philippe, S. Taïeb, & Philippe Carpentier. (2001). Le patient face aux choix thérapeutiques en cancérologie : vers une décision partagée ?. Bulletin du Cancer. 88(4). 3 indexed citations
10.
Eisinger, François, Dominique Stoppa-Lyonnet, Christine Lasset, et al.. (2001). Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys. Familial Cancer. 1(3-4). 157–162. 11 indexed citations
11.
Leblanc, Éric, Denis Querleu, Fabrice Narducci, et al.. (2000). Surgical staging of early invasive epithelial ovarian tumors. Seminars in Surgical Oncology. 19(1). 36–41. 37 indexed citations
12.
Julian‐Reynier, Claire, François Eisinger, F Chabal, et al.. (2000). Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factors. American Journal of Medical Genetics. 94(1). 13–18. 93 indexed citations
13.
Delozier, T., M. Spielmann, Josette Macé-Lesec’h, et al.. (2000). Tamoxifen Adjuvant Treatment Duration in Early Breast Cancer: Initial Results of a Randomized Study Comparing Short-Term Treatment With Long-Term Treatment. Journal of Clinical Oncology. 18(20). 3507–3512. 35 indexed citations
14.
Eisinger, François, Jean‐Philippe Peyrat, Tetsuro Noguchi, et al.. (1999). Novel indications forBRCA1 screening using individual clinical and morphological features. International Journal of Cancer. 84(3). 263–267. 39 indexed citations
15.
Adenis, Antoine, Philippe Vennin, & B Hecquet. (1998). L'information des patients atteints d'un cancer du côlon : résultats d'une enquête réalisée auprès des gastroentérologues, chirurgiens et cancérologues de la région Nord. Bulletin du Cancer. 85(9). 803–808. 2 indexed citations
16.
Julian‐Reynier, Claire, François Eisinger, F Chabal, et al.. (1998). Cancer genetic clinics: why do women who already have cancer attend?. European Journal of Cancer. 34(10). 1549–1553. 38 indexed citations
17.
Peyrat, J.P., Philippe Vennin, Louis Hornez, et al.. (1998). Germline BRCA1 mutations in patients from 84 families with breast and/or ovarian cancers in northern France. European Journal of Cancer Prevention. 7. S7–S12. 5 indexed citations
18.
Peyrat, Jean‐Philippe, Philippe Vennin, Louis Hornez, & Jacques Bonneterre. (1997). Germline BRCA1 mutations in patients from 36 families with breast and/or ovarian cancers in Northern France. Bulletin du Cancer. 84(1). 1 indexed citations
19.
Julian‐Reynier, Claire, François Eisinger, F Chabal, et al.. (1996). Cancer genetics clinics: Target population and consultees' expectations. European Journal of Cancer. 32(3). 398–403. 32 indexed citations
20.
Vennin, Philippe, et al.. (1995). Cancer du sein : l'information en question(s). Enquête auprès des patientes et des médecins d'un Centre de lutte contre le cancer. Bulletin du Cancer. 82(82). 698–704. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen M. Shannon Breakdown of academic impact, for papers by Anne Dørum Breakdown of academic impact, for papers by Richard M. Brohet Breakdown of academic impact, for papers by Amy Finch Breakdown of academic impact, for papers by Rochelle Demsky Breakdown of academic impact, for papers by Julie Dutil Breakdown of academic impact, for papers by Dana Zakalik Breakdown of academic impact, for papers by Susan Randall Armel Breakdown of academic impact, for papers by Shu Yuasa Breakdown of academic impact, for papers by Mary‐Anne Young
Rankless by CCL
2026